Cargando…
Cell-free DNA analysis in current cancer clinical trials: a review
Cell-free DNA (cfDNA) analysis represents a promising method for the diagnosis, treatment selection and clinical follow-up of cancer patients. Although its general methodological feasibility and usefulness has been demonstrated, several issues related to standardisation and technical validation must...
Autores principales: | Cisneros-Villanueva, M., Hidalgo-Pérez, L., Rios-Romero, M., Cedro-Tanda, A., Ruiz-Villavicencio, C. A., Page, K., Hastings, R., Fernandez-Garcia, D., Allsopp, R., Fonseca-Montaño, M. A., Jimenez-Morales, S., Padilla-Palma, V., Shaw, J. A., Hidalgo-Miranda, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810765/ https://www.ncbi.nlm.nih.gov/pubmed/35027672 http://dx.doi.org/10.1038/s41416-021-01696-0 |
Ejemplares similares
-
Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism
por: Beltrán-Anaya, Fredy O., et al.
Publicado: (2016) -
A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype
por: Cedro-Tanda, Alberto, et al.
Publicado: (2020) -
LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancer
por: Fonseca-Montaño, Marco Antonio, et al.
Publicado: (2023) -
FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PR + BRCA patients
por: Ríos-Romero, Magdalena, et al.
Publicado: (2020) -
LINC00460 Is a Dual Biomarker That Acts as a Predictor for Increased Prognosis in Basal-Like Breast Cancer and Potentially Regulates Immunogenic and Differentiation-Related Genes
por: Cisneros-Villanueva, Mireya, et al.
Publicado: (2021)